The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated overall survival (OS) results from the phase III MONALEESA-3 trial of postmenopausal patients (pts) with HR+/HER2- advanced breast cancer (ABC) treated with fulvestrant (FUL) ± ribociclib (RIB).
 
Dennis J. Slamon
Leadership - Biomarin
Stock and Other Ownership Interests - Amgen; Amgen; BioMarin; Merck Sharp & Dohme; Pfizer; Seagen; Vertex
Honoraria - Novartis
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Seagen
Research Funding - Novartis; Pfizer
Travel, Accommodations, Expenses - Biomarin; Novartis; Pfizer
 
Patrick Neven
Consulting or Advisory Role - Lilly (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Radius Health (Inst); Roche (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Lilly (Inst); Pfizer (Inst); Roche (Inst)
 
Stephen K. L. Chia
Honoraria - AstraZeneca; Exact Sciences; Lilly; Merck; Novartis; Pfizer; Roche
Consulting or Advisory Role - Novartis; Roche
Research Funding - AstraZeneca (Inst); Genentech (Inst); Genomic Health (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst)
 
Guy Heinrich Maria Jerusalem
Honoraria - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichy Sankyo; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Lilly; Novartis; Pfizer; Roche
Research Funding - Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Amgen; AstraZeneca; BMS; Lilly; Medimmune; Merck; Novartis; Pfizer; Roche
 
Michelino De Laurentiis
Honoraria - Amgen; AstraZeneca; Celgene; Eisai; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Eisai; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche
Speakers' Bureau - Novartis
Research Funding - Bristol-Myers Squibb; Daiichi Sankyo; Lilly; Macrogenics; MSD; Novartis; Pfizer; Puma Biotechnology; Roche
 
Seock-Ah Im
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo; Eisai; GlaxoSmithKline; Hanmi; Lilly; MSD; Novartis; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); Daewoong Pharmaceutical (Inst); Eisai (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Other Relationship - Roche
 
Katarina Petrakova
Honoraria - AstraZeneca; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Roche
 
Giulia Valeria Bianchi
Honoraria - Lilly; Novartis
Consulting or Advisory Role - Lilly; Novartis
 
Miguel Martin
Honoraria - Lilly; Novartis; Pfizer; Pierre Fabre; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Pfizer; PharmaMar; Roche/Genentech; Taiho Pharmaceutical
Speakers' Bureau - Lilly/ImClone; Lilly/ImClone; Pierre Fabre; Roche/Genentech
Research Funding - Novartis (Inst); Puma Biotechnology (Inst); Roche (Inst)
Other Relationship - Novartis; Roche
 
Arnd Nusch
Honoraria - Amgen; Novartis
Consulting or Advisory Role - Amgen; Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
 
Gabe S. Sonke
Consulting or Advisory Role - Biovica (Inst); Novartis (Inst); Seagen (Inst)
Research Funding - Merck Sharp & Dohme (Inst)
 
Luis de la Cruz-Merino
Consulting or Advisory Role - Bristol-Myers Squibb; MSD Oncology; Novartis; Roche
Research Funding - Celgene (Inst); Celgene (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
J. Thaddeus Beck
Research Funding - AbbVie (Inst); Amgen (Inst); AstraZeneca (Inst); DSi (Inst); Genentech/Roche (Inst); Lilly (Inst); Nektar (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Seattle Genetics/Astellas (Inst)
 
Craig Wang
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Uday Deore
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Arunava Chakravartty
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Juan Pablo Zarate
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Tetiana Taran
Employment - Novartis; Novartis
Stock and Other Ownership Interests - Novartis
 
Peter A. Fasching
Honoraria - Agendia; AstraZeneca; BionTech (Inst); Cepheid (Inst); Daiichi Sankyo; Eisai; Hexal; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Consulting or Advisory Role - Agendia; AstraZeneca; Daiichi Sankyo; Eisai; Hexal; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Research Funding - BioNTech (Inst); Cepheid (Inst); Novartis (Inst)